Zusammenfassung
Bei Diagnose eines Mammakarzinoms gibt es mehrere klinische Befunde, neben der Stanzbiopsie und der Immunhistochemie, die erhoben werden sollten. Am Anfang der diagnostischen Kette steht die Inspektion und Palpation der Brust.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Literatur
Aebi DR, Allegra CJ, Ganschow P et al (2010) Primary breast cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 2010(5):9–14
Arbeitsgemeinschaft Gynäkologische Onkologie – AGO (2018) AGO-Therapieempfehlungen. https://www.ago-online.de/fileadmin/downloads/leitlinien/mamma/2018-03/AGO_2018_PDF_Deutsch%20mit%20Literatur/2018D%2007_DCIS_mit%20Literatur.pdf
Arbeitsgemeinschaft Gynäkologische Onkologie – AGO (2018) AGO-Therapieempfehlungen. https://www.ago-online.de/fileadmin/downloads/leitlinien/mamma/2018-03/AGO_2018_PDF_Deutsch/2018D%2008_Operative%20Therapie%20des%20Mammakarzinoms%20unter%20onkologischen%20Aspekten.pdf
Arbeitsgemeinschaft Gynäkologische Onkologie – AGO (2018) AGO Therapieempfehlungen. https://www.ago-online.de/fileadmin/downloads/leitlinien/mamma/2018-03/AGO_2018_PDF_Deutsch%20mit%20Literatur/2018D%2005_Prognostische%20und%20praediktive%20Faktoren_mit%20Literatur.pdf
Barton MB, Harris R, Flezcher SW (1999) Does this patient have breast cancer? The screening clinical breast examination should it be done? How? JAMA 282:1270–1280
Bloom HJG, Richardson WW (1957) Histological grading and prognosis in breast cancer. A study of 1049 cases, of which 359 have been followed 15 years. Br J Cancer 11:359–377
Denkert C, Loibl S, Müller BM et al (2013) Ki67 levels as predictive and prognostic parameters in pretherapeutic breast cancer core biopsies: a translational investigation in the neoadjuvant GeparTrio trial. Ann Oncol 24(11):2786–2793
Dunne C, Burke JP, Marrow M et al (2009) Effect of margin status on local recurrence after breast conservation and radiation therapy for ductal caarcinoma in situ. J Clin Oncol 27:1615–1620
Early Breast Cancer Trialists‘ Collaborative Group – EBCTCG (2011) Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient level meta-analysis of randomized trials. Lancet 378:771–784
Fisher B, Anderon S (1994) Conservative surgery for the management of invasive and noninvasive carcinoma of the breast: NSABP trials. World J Surg 18:63–69
Fisher B, Anderson S, Redmond CK, Wolmark N, Wickerham DL, Cronin WM (1995) Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breat cancer. N Engl J Med 333:1456–1461
Fisher B, Land S, Mamounas E et al (2001) Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the National Surgical Adjuvant Breast and Bowel Project experience. Semin Oncol 28(4):400–418
Fuchs R, Guggenberger D, Karl C (Hrsg) (2004/2005) Mammakarzinom – Diagnostik und Therapie. Manual des Euregio-Brustzentrums (Sitz Eschweiler). Roche, Basel
Galimberti V, Cole BF, Zurrida S et al (2011) International, and B.C.S.G.T.-Investigators. Update of International Breast Cancer Study Group trial 23–01 to compare axillary dissection versus no axillary dissection in patients with clinically node negative breast cancer and micrometastasis in the sentinel lymph node SABCS Abstract, S 3–1
Gerber B et al (2009) The oncological safety of skin sparing mastectomy with conservation of the nipple-areola complex and autologous reconstruction: an extended follow-upü study. Ann Surg 249:461–468
Giuliano AE, Hunt KK, Ballman KV et al (2011) Axillary dissection vs. no axillary dissection in women with invasive breast cancer and sentinel lymph node metastases. JAMA 305:569–575
Goldhirsch A, Wood WC, Coates AS et al (2011) Strategies for subtypes – dealing with the diversity of breast cancer: highlights of the St. Gallen international expert consensus on the primary therapy of early breast cancer. Ann Oncol 22:1737–1747
Halsted WS (1894) The results of operations for the cure of cancer of breast performed at the Johns Hopkins Hospital from June 1989 to January 1894. Johns Hopk Hosp Rep 4:297
Inwald EC, Koller M, Klinkhammer-Schalke M et al (2016) Klaus-Dieter-Schulz-Versorgungsforschungspreis – Gelingt die tumorbiologische Subtypisierung bei Patientinnen mit Mammakarzinom in der klinischen Routine? – Ergebnisse aus einer großen Kohorte eines klinischen Krebsregisters. Senologie-Zeitschrift für Mammadiagnostik und-therapie 13(03):107–108
Jäger B, Schochter F, Scholz C et al (2013) Zirkulierende Tumorzellen beim Mammakarzinom. Gynäkologe 46(6):382–385
Kooperationsgemeinschaft Mammographie (2009) Evaluationsbericht 2005–2007. http://mammo-programm.de/cms_upload/datenpool/evaluationsbericht05-07_web.pdf
Krag DN, Anderson SJ, Julian TB et al (2010) Primary outcome results of NSABP B-32 – a randomized phase III clinical trial to compare Sentinel Node Resection (SNR) to conventional Axillary Dissection (AD) in clinically node-negative breast cancer patients. J Clin Oncol 28(18):Abstract LBA 505
Kreienberg R, Kopp I, Albert US et al (2008) Interdisziplinäre S3-Leitlinie für die Diagnostik. Therapie und Nachsorge des Mammakarzinoms. Deutsche Krebsgesellschaft e. V, Zuckschwerdt, München
Kreienberg R, Jonat W, Volm T, Möbus V, Alt D (2006) Management des Mammakarzinoms, 3. Aufl. Springer, Heidelberg
Kühn T, Santjohanser C, Kreienberg R (2000) Bedeutung des Sentinel-Lymphknotens. Dtsch Ärztebl 97:2102–2105
Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF): S3-Leitlinie Früherkennung, Diagnose, Therapie und Nachsorge des Mammakarzinoms, Version 4.0, 2017 AWMF Registernummer: 032-045OL, http://www.leitlinienprogramm-onkologie.de/leitlinien/mammakarzinom/. Zugegriffen: 22. Aug. 2018
Malek D, Rabe P (2011) Mammografie-Screening-Programm. http://mammo-programm.de/cms_upload/datenpool/evaluationsbericht05-07_web.pdf (Stand 27.06.2011)
Melcher C et al (2012) Breast cancer – state of the art. Geburtsh Frauenheilkd 72:215–224
Petrelli F, Barni S (2011) Tamoxifen added to radiotherapy and surgery fort he treatment of ductal carcinoma in situ of the breast: a met-analysis of 2 randomized trials. Radiother Oncol 100:195–199
Rack BK, Schindlbeck C, Andergassen U et al (2010) Use of Circulating Tumor Cells (CTC) in peripheral blood of breast cancer patients before and after adjuvant chemotherapy to predict risk for relapse: the SUCCESS trial. J Clin Oncol 28(15):1003–1003
Sener SF, Winchester DJ, Winchester DP (1999) Spectrum of mammographically detected breast cancers. Am Surg 65:731–735
Tavassoli FA (2008) Lobular and ductal intraepithelial neoplasia. Pathologe 29(2):107–111
Thill M, Kapsimalakou S, Diedrich K, Baumann K (2012) Behandlung des duktalen Carcinoma in situ. Gynäkologe 45:269–275
Tzschaschel M, Löhberg C, Beck T et al (2016) TREAT CTC: Eine innovative Studie zur Eliminierung von zirkulierenden Tumorzellen (CTCs) beim frühen Mammakarzinom. Geburtshilfe Frauenheilkd 76(4):PD42
Untch M, Gerber B, Möbus V et al (2011) Zürich consensus statement of German experts on St. Gallen conference 2011 on breast cancer (Zürich 2011). Geburtshilfe Frauenheilkd 71:381–390
Veronesi U, Rilke F, Luini A, Sacchini V, Galimberti V, Campa T (1987) Distribution of axillary node metastases by level of invasion. Cancer 59:682–687
Veronesi U, Banfi A, Salvadori B, Luini A (1990) Breast conservation is the treatment of choice in small breast cancer: long-term results of a randomiszed trial. Eur J Cancer 26:668–670
Veronesi U, Paganelli G, Viale G (1999) Sentinel lymph node and axillary dissection in breast cancer: results in a large series. J Natl Cancer Inst 91:368–373
Voogd AC, Nielsen M, Peterse JL et al (2001) Danish Breast Cancer Cooperative Group. Differences in risk factors for local and distant recurrence of breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomized trials. J Clin Oncol 19:1688–1697
Wittekind C, Meyer H-J (Hrsg) (2010) TNM-Klassifikation maligner Tumoren, 7. Aufl. Wiley-VCH, Weinheim
Yeh I, Fowble B, Vigione MJ et al (1991) Pathologic assessment and pathologic prognostic factors in operable breast cancer. In: Fowble B, Goodman RL, Glick JH, Rosato EF (Hrsg) Breast cancer treatment: a comprehensive guide to treatment. Mosby-Yearbook, St. Louis, S 171
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature
About this chapter
Cite this chapter
Ernst, K. et al. (2020). Maligne Tumoren der Mamma. In: Wacker, J., Sillem, M., Bastert, G., Beckmann, M. (eds) Therapiehandbuch Gynäkologie und Geburtshilfe. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-59809-2_30
Download citation
DOI: https://doi.org/10.1007/978-3-662-59809-2_30
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-59808-5
Online ISBN: 978-3-662-59809-2
eBook Packages: Medicine (German Language)